Analogy of human immunodeficiency virus to hepatitis C virus: The human immunodeficiency model

American Journal of Medicine

Volumn 107, Issue 6 SUPPL. 2, 1999, Pages 41-44

  Pollard, Richard B ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR; RIBAVIRIN; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; DISEASE COURSE; DRUG RESISTANCE; GENETIC HETEROGENEITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MIXED INFECTION; MORTALITY; PRIORITY JOURNAL; VIRUS LOAD; VIRUS REPLICATION;

EID: 0033375484     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00380-0     Document Type: Conference Paper

References (11)

1. Friedman S.L. The evaluation of fibrosis and hepatitis C. Am J Med. 107:1999;27S-30S.
2. Haynes B.F. Immune response to human immunodeficiency virus infection. DeVita V.T. Jr, Hellman S., Rosenberg S.A., et al. AIDS Etiology, Diagnosis, Treatment and Prevention. 4th ed . 1997;89-99 Lippincott-Raven Publishers, Philadelphia.
3. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 126:1997;946-954.
4. Richman D.D., Havlir D., Corbeil J., et al. Nevirapine resis-tance mutations of human imunodeficiency virus type 1 selected during therapy. J Virol. 68:1994;1660-1666.
5. Palella F.J. Jr, Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 338:1998;853-860.
6. Bacon B.R. Available options for treatment of interferon nonresponders. Am J Med. 107:1999;67S-70S.
7. Jacobson I. Management of interferon relapsers. Am J Med. 107:1999;62S-66S.
8. Layden T.J. Principles of interferon induction therapy. Am J Med. 107:1999;71S-73S.
9. Di Bisceglie A.M. Hepatitis C - virology and future antiviral targets. Am J Med. 107:1999;45S-48S.
10. Perelson A.S. Viral kinetics and mathematical models. Am J Med. 107:1999;49S-52S.
11. Dieterich D.T. Hepatitis C virus and human immunodeficiency virus clinical issues in coinfection . Am J Med. 107:1999;79S-84S.